- Využití léku Isoprinosine v léčbě chronických a recidivujících onemocnění2017 | Publication without faculty affiliation
- Mortality of hospitalized patients with COVID-19: Effects of treatment options (vitamin D, anticoagulation, isoprinosine, ivermectin) assessed by propensity score matching, retrospective analysis2023 | Publication without faculty affiliation
- Subacute Sclerosing Panencephalitis2002 | First Faculty of Medicine
- Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases2019 | Central Library of Charles University, Third Faculty of Medicine
- Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study2016 | Second Faculty of Medicine
- Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course2021 | Third Faculty of Medicine
- Podávání inosinum pranobex u onemocnění COVID-192020 | First Faculty of Medicine
- The role of immunomodulators in the treatment of respiratory and allergic diseases2007 | Second Faculty of Medicine
- Optimizing clinical approaches to COVID-19 patients in primary care2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Optimizing clinical approaches to COVID-19 patients in primary care2021 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic2020 | First Faculty of Medicine